| First Author | Heidt AB | Year | 2005 |
| Journal | Genesis | Volume | 42 |
| Issue | 1 | Pages | 28-32 |
| PubMed ID | 15828002 | Mgi Jnum | J:99340 |
| Mgi Id | MGI:3582005 | Doi | 10.1002/gene.20123 |
| Citation | Heidt AB, et al. (2005) Transgenic mice that express Cre recombinase under control of a skeletal muscle-specific promoter from mef2c. Genesis 42(1):28-32 |
| abstractText | Genes expressed in skeletal muscle are often required in other tissues. This is particularly the case for cardiac and smooth muscle, both contractile tissues that share numerous characteristics with skeletal muscle, such that targeted inactivation can lead to embryonic lethality prior to a requirement for gene function in skeletal muscle. Thus, it is essential that conditional inactivation approaches are developed to disrupt genes specifically in skeletal muscle. In this report, we describe a transgenic mouse that expresses Cre recombinase under the control of a skeletal muscle-specific promoter from the mef2c gene. Cre expression in this transgenic line is completely restricted to skeletal muscle from early in development and is present in all skeletal muscles, including those of epaxial and hypaxial origins and in fast and slow fibers. This early skeletal muscle-specific Cre line will be a useful tool to define the function of genes specifically in skeletal muscle. |
